112 related articles for article (PubMed ID: 14625571)
1. Conditional expression of alpha1-antitrypsin delivered by recombinant SV40 vectors protects lymphocytes against HIV.
Cordelier P; Strayer DS
Gene Ther; 2003 Dec; 10(26):2153-6. PubMed ID: 14625571
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 proprotein processing as a target for gene therapy.
Cordelier P; Zern MA; Strayer DS
Gene Ther; 2003 Mar; 10(6):467-77. PubMed ID: 12621451
[TBL] [Abstract][Full Text] [Related]
3. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
[TBL] [Abstract][Full Text] [Related]
6. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
Cordelier P; Strayer DS
Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.
Li Y; Starr SE; Lisziewicz J; Ho WZ
Gene Ther; 2000 Feb; 7(4):321-8. PubMed ID: 10694813
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
9. Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma.
Matskevich AA; Strayer DS
Gene Ther; 2003 Oct; 10(22):1861-73. PubMed ID: 14502215
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
[TBL] [Abstract][Full Text] [Related]
11. Trans-activated interferon-alpha2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle.
Cordelier P; Calarota SA; Strayer DS
J Hematother Stem Cell Res; 2002 Oct; 11(5):817-28. PubMed ID: 12427288
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.
Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Fanning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray J; Gerlach W; Sun LQ; Penny R; Symonds GP; Carr A; Cooper DA
J Gene Med; 2005 May; 7(5):552-64. PubMed ID: 15655805
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
14. Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection.
Marusich EI; Parveen Z; Strayer D; Mukhtar M; Dornburg RC; Pomerantz RJ
Virology; 2005 Feb; 332(1):258-71. PubMed ID: 15661158
[TBL] [Abstract][Full Text] [Related]
15. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.
Sakuma R; Noser JA; Ohmine S; Ikeda Y
Gene Ther; 2007 Jan; 14(2):185-9. PubMed ID: 16943852
[TBL] [Abstract][Full Text] [Related]
17. A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line.
Zern MA; Ozaki I; Duan L; Pomerantz R; Liu SL; Strayer DS
Gene Ther; 1999 Jan; 6(1):114-20. PubMed ID: 10341883
[TBL] [Abstract][Full Text] [Related]
18. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.
Cordelier P; Calarota SA; Pomerantz RJ; Xiaoshan J; Strayer DS
J Interferon Cytokine Res; 2003 Sep; 23(9):477-88. PubMed ID: 14565857
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of alpha1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis.
Cordelier P; Strayer DS
Biochim Biophys Acta; 2003 Jul; 1638(3):197-207. PubMed ID: 12878320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
